Veterinary Pharmaceuticals-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Veterinary Pharmaceuticals-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Veterinary Pharmaceuticals industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Veterinary Pharmaceuticals 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Veterinary Pharmaceuticals worldwide and market share by regions, with company and product introduction, position in the Veterinary Pharmaceuticals market
Market status and development trend of Veterinary Pharmaceuticals by types and applications
Cost and profit status of Veterinary Pharmaceuticals, and marketing status
Market growth drivers and challenges
The report segments the global Veterinary Pharmaceuticals market as:
Global Veterinary Pharmaceuticals Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Veterinary Pharmaceuticals Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Veterinary Biological Drugs
Veterinary Preparations
Others
Global Veterinary Pharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Poultry
Pets
Other
Global Veterinary Pharmaceuticals Market: Manufacturers Segment Analysis (Company and Product introduction, Veterinary Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Zoetis(Pfizer)
MERIAL
Merial
Lilly
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
CAHIC
Ringpu
Dahuanong
TECON
BIOK
Lukang Pharma
JINYU Group
China Animal Healthcare
Jiangxi Yiling
JIZHONG Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Veterinary Pharmaceuticals-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Veterinary Pharmaceuticals industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Veterinary Pharmaceuticals 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Veterinary Pharmaceuticals worldwide and market share by regions, with company and product introduction, position in the Veterinary Pharmaceuticals market
Market status and development trend of Veterinary Pharmaceuticals by types and applications
Cost and profit status of Veterinary Pharmaceuticals, and marketing status
Market growth drivers and challenges
The report segments the global Veterinary Pharmaceuticals market as:
Global Veterinary Pharmaceuticals Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Veterinary Pharmaceuticals Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Veterinary Biological Drugs
Veterinary Preparations
Others
Global Veterinary Pharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Poultry
Pets
Other
Global Veterinary Pharmaceuticals Market: Manufacturers Segment Analysis (Company and Product introduction, Veterinary Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Zoetis(Pfizer)
MERIAL
Merial
Lilly
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
CAHIC
Ringpu
Dahuanong
TECON
BIOK
Lukang Pharma
JINYU Group
China Animal Healthcare
Jiangxi Yiling
JIZHONG Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF VETERINARY PHARMACEUTICALS
1.1 Definition of Veterinary Pharmaceuticals in This Report
1.2 Commercial Types of Veterinary Pharmaceuticals
1.2.1 Veterinary Biological Drugs
1.2.2 Veterinary Preparations
1.2.3 Others
1.3 Downstream Application of Veterinary Pharmaceuticals
1.3.1 Poultry
1.3.2 Pets
1.3.3 Other
1.4 Development History of Veterinary Pharmaceuticals
1.5 Market Status and Trend of Veterinary Pharmaceuticals 2013-2023
1.5.1 Global Veterinary Pharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Veterinary Pharmaceuticals Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Veterinary Pharmaceuticals 2013-2017
2.2 Sales Market of Veterinary Pharmaceuticals by Regions
2.2.1 Sales Volume of Veterinary Pharmaceuticals by Regions
2.2.2 Sales Value of Veterinary Pharmaceuticals by Regions
2.3 Production Market of Veterinary Pharmaceuticals by Regions
2.4 Global Market Forecast of Veterinary Pharmaceuticals 2018-2023
2.4.1 Global Market Forecast of Veterinary Pharmaceuticals 2018-2023
2.4.2 Market Forecast of Veterinary Pharmaceuticals by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Veterinary Pharmaceuticals by Types
3.2 Sales Value of Veterinary Pharmaceuticals by Types
3.3 Market Forecast of Veterinary Pharmaceuticals by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Veterinary Pharmaceuticals by Downstream Industry
4.2 Global Market Forecast of Veterinary Pharmaceuticals by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Veterinary Pharmaceuticals Market Status by Countries
5.1.1 North America Veterinary Pharmaceuticals Sales by Countries (2013-2017)
5.1.2 North America Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
5.1.3 United States Veterinary Pharmaceuticals Market Status (2013-2017)
5.1.4 Canada Veterinary Pharmaceuticals Market Status (2013-2017)
5.1.5 Mexico Veterinary Pharmaceuticals Market Status (2013-2017)
5.2 North America Veterinary Pharmaceuticals Market Status by Manufacturers
5.3 North America Veterinary Pharmaceuticals Market Status by Type (2013-2017)
5.3.1 North America Veterinary Pharmaceuticals Sales by Type (2013-2017)
5.3.2 North America Veterinary Pharmaceuticals Revenue by Type (2013-2017)
5.4 North America Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Veterinary Pharmaceuticals Market Status by Countries
6.1.1 Europe Veterinary Pharmaceuticals Sales by Countries (2013-2017)
6.1.2 Europe Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
6.1.3 Germany Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.4 UK Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.5 France Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.6 Italy Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.7 Russia Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.8 Spain Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.9 Benelux Veterinary Pharmaceuticals Market Status (2013-2017)
6.2 Europe Veterinary Pharmaceuticals Market Status by Manufacturers
6.3 Europe Veterinary Pharmaceuticals Market Status by Type (2013-2017)
6.3.1 Europe Veterinary Pharmaceuticals Sales by Type (2013-2017)
6.3.2 Europe Veterinary Pharmaceuticals Revenue by Type (2013-2017)
6.4 Europe Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Veterinary Pharmaceuticals Market Status by Countries
7.1.1 Asia Pacific Veterinary Pharmaceuticals Sales by Countries (2013-2017)
7.1.2 Asia Pacific Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
7.1.3 China Veterinary Pharmaceuticals Market Status (2013-2017)
7.1.4 Japan Veterinary Pharmaceuticals Market Status (2013-2017)
7.1.5 India Veterinary Pharmaceuticals Market Status (2013-2017)
7.1.6 Southeast Asia Veterinary Pharmaceuticals Market Status (2013-2017)
7.1.7 Australia Veterinary Pharmaceuticals Market Status (2013-2017)
7.2 Asia Pacific Veterinary Pharmaceuticals Market Status by Manufacturers
7.3 Asia Pacific Veterinary Pharmaceuticals Market Status by Type (2013-2017)
7.3.1 Asia Pacific Veterinary Pharmaceuticals Sales by Type (2013-2017)
7.3.2 Asia Pacific Veterinary Pharmaceuticals Revenue by Type (2013-2017)
7.4 Asia Pacific Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Veterinary Pharmaceuticals Market Status by Countries
8.1.1 Latin America Veterinary Pharmaceuticals Sales by Countries (2013-2017)
8.1.2 Latin America Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
8.1.3 Brazil Veterinary Pharmaceuticals Market Status (2013-2017)
8.1.4 Argentina Veterinary Pharmaceuticals Market Status (2013-2017)
8.1.5 Colombia Veterinary Pharmaceuticals Market Status (2013-2017)
8.2 Latin America Veterinary Pharmaceuticals Market Status by Manufacturers
8.3 Latin America Veterinary Pharmaceuticals Market Status by Type (2013-2017)
8.3.1 Latin America Veterinary Pharmaceuticals Sales by Type (2013-2017)
8.3.2 Latin America Veterinary Pharmaceuticals Revenue by Type (2013-2017)
8.4 Latin America Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Veterinary Pharmaceuticals Market Status by Countries
9.1.1 Middle East and Africa Veterinary Pharmaceuticals Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
9.1.3 Middle East Veterinary Pharmaceuticals Market Status (2013-2017)
9.1.4 Africa Veterinary Pharmaceuticals Market Status (2013-2017)
9.2 Middle East and Africa Veterinary Pharmaceuticals Market Status by Manufacturers
9.3 Middle East and Africa Veterinary Pharmaceuticals Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Veterinary Pharmaceuticals Sales by Type (2013-2017)
9.3.2 Middle East and Africa Veterinary Pharmaceuticals Revenue by Type (2013-2017)
9.4 Middle East and Africa Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF VETERINARY PHARMACEUTICALS
10.1 Global Economy Situation and Trend Overview
10.2 Veterinary Pharmaceuticals Downstream Industry Situation and Trend Overview
CHAPTER 11 VETERINARY PHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Veterinary Pharmaceuticals by Major Manufacturers
11.2 Production Value of Veterinary Pharmaceuticals by Major Manufacturers
11.3 Basic Information of Veterinary Pharmaceuticals by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Veterinary Pharmaceuticals Major Manufacturer
11.3.2 Employees and Revenue Level of Veterinary Pharmaceuticals Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 VETERINARY PHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Zoetis(Pfizer)
12.1.1 Company profile
12.1.2 Representative Veterinary Pharmaceuticals Product
12.1.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Zoetis(Pfizer)
12.2 MERIAL
12.2.1 Company profile
12.2.2 Representative Veterinary Pharmaceuticals Product
12.2.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of MERIAL
12.3 Merial
12.3.1 Company profile
12.3.2 Representative Veterinary Pharmaceuticals Product
12.3.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Merial
12.4 Lilly
12.4.1 Company profile
12.4.2 Representative Veterinary Pharmaceuticals Product
12.4.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Lilly
12.5 Bayer
12.5.1 Company profile
12.5.2 Representative Veterinary Pharmaceuticals Product
12.5.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Bayer
12.6 Boehringer
12.6.1 Company profile
12.6.2 Representative Veterinary Pharmaceuticals Product
12.6.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Boehringer
12.7 Novartis
12.7.1 Company profile
12.7.2 Representative Veterinary Pharmaceuticals Product
12.7.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Novartis
12.8 Virbac
12.8.1 Company profile
12.8.2 Representative Veterinary Pharmaceuticals Product
12.8.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Virbac
12.9 Ceva
12.9.1 Company profile
12.9.2 Representative Veterinary Pharmaceuticals Product
12.9.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Ceva
12.10 Vetoquinol
12.10.1 Company profile
12.10.2 Representative Veterinary Pharmaceuticals Product
12.10.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Vetoquinol
12.11 CAHIC
12.11.1 Company profile
12.11.2 Representative Veterinary Pharmaceuticals Product
12.11.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of CAHIC
12.12 Ringpu
12.12.1 Company profile
12.12.2 Representative Veterinary Pharmaceuticals Product
12.12.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Ringpu
12.13 Dahuanong
12.13.1 Company profile
12.13.2 Representative Veterinary Pharmaceuticals Product
12.13.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Dahuanong
12.14 TECON
12.14.1 Company profile
12.14.2 Representative Veterinary Pharmaceuticals Product
12.14.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of TECON
12.15 BIOK
12.15.1 Company profile
12.15.2 Representative Veterinary Pharmaceuticals Product
12.15.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of BIOK
12.16 Lukang Pharma
12.17 JINYU Group
12.18 China Animal Healthcare
12.19 Jiangxi Yiling
12.20 JIZHONG Pharmaceutical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VETERINARY PHARMACEUTICALS
13.1 Industry Chain of Veterinary Pharmaceuticals
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF VETERINARY PHARMACEUTICALS
14.1 Cost Structure Analysis of Veterinary Pharmaceuticals
14.2 Raw Materials Cost Analysis of Veterinary Pharmaceuticals
14.3 Labor Cost Analysis of Veterinary Pharmaceuticals
14.4 Manufacturing Expenses Analysis of Veterinary Pharmaceuticals
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Veterinary Pharmaceuticals in This Report
1.2 Commercial Types of Veterinary Pharmaceuticals
1.2.1 Veterinary Biological Drugs
1.2.2 Veterinary Preparations
1.2.3 Others
1.3 Downstream Application of Veterinary Pharmaceuticals
1.3.1 Poultry
1.3.2 Pets
1.3.3 Other
1.4 Development History of Veterinary Pharmaceuticals
1.5 Market Status and Trend of Veterinary Pharmaceuticals 2013-2023
1.5.1 Global Veterinary Pharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Veterinary Pharmaceuticals Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Veterinary Pharmaceuticals 2013-2017
2.2 Sales Market of Veterinary Pharmaceuticals by Regions
2.2.1 Sales Volume of Veterinary Pharmaceuticals by Regions
2.2.2 Sales Value of Veterinary Pharmaceuticals by Regions
2.3 Production Market of Veterinary Pharmaceuticals by Regions
2.4 Global Market Forecast of Veterinary Pharmaceuticals 2018-2023
2.4.1 Global Market Forecast of Veterinary Pharmaceuticals 2018-2023
2.4.2 Market Forecast of Veterinary Pharmaceuticals by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Veterinary Pharmaceuticals by Types
3.2 Sales Value of Veterinary Pharmaceuticals by Types
3.3 Market Forecast of Veterinary Pharmaceuticals by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Veterinary Pharmaceuticals by Downstream Industry
4.2 Global Market Forecast of Veterinary Pharmaceuticals by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Veterinary Pharmaceuticals Market Status by Countries
5.1.1 North America Veterinary Pharmaceuticals Sales by Countries (2013-2017)
5.1.2 North America Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
5.1.3 United States Veterinary Pharmaceuticals Market Status (2013-2017)
5.1.4 Canada Veterinary Pharmaceuticals Market Status (2013-2017)
5.1.5 Mexico Veterinary Pharmaceuticals Market Status (2013-2017)
5.2 North America Veterinary Pharmaceuticals Market Status by Manufacturers
5.3 North America Veterinary Pharmaceuticals Market Status by Type (2013-2017)
5.3.1 North America Veterinary Pharmaceuticals Sales by Type (2013-2017)
5.3.2 North America Veterinary Pharmaceuticals Revenue by Type (2013-2017)
5.4 North America Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Veterinary Pharmaceuticals Market Status by Countries
6.1.1 Europe Veterinary Pharmaceuticals Sales by Countries (2013-2017)
6.1.2 Europe Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
6.1.3 Germany Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.4 UK Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.5 France Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.6 Italy Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.7 Russia Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.8 Spain Veterinary Pharmaceuticals Market Status (2013-2017)
6.1.9 Benelux Veterinary Pharmaceuticals Market Status (2013-2017)
6.2 Europe Veterinary Pharmaceuticals Market Status by Manufacturers
6.3 Europe Veterinary Pharmaceuticals Market Status by Type (2013-2017)
6.3.1 Europe Veterinary Pharmaceuticals Sales by Type (2013-2017)
6.3.2 Europe Veterinary Pharmaceuticals Revenue by Type (2013-2017)
6.4 Europe Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Veterinary Pharmaceuticals Market Status by Countries
7.1.1 Asia Pacific Veterinary Pharmaceuticals Sales by Countries (2013-2017)
7.1.2 Asia Pacific Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
7.1.3 China Veterinary Pharmaceuticals Market Status (2013-2017)
7.1.4 Japan Veterinary Pharmaceuticals Market Status (2013-2017)
7.1.5 India Veterinary Pharmaceuticals Market Status (2013-2017)
7.1.6 Southeast Asia Veterinary Pharmaceuticals Market Status (2013-2017)
7.1.7 Australia Veterinary Pharmaceuticals Market Status (2013-2017)
7.2 Asia Pacific Veterinary Pharmaceuticals Market Status by Manufacturers
7.3 Asia Pacific Veterinary Pharmaceuticals Market Status by Type (2013-2017)
7.3.1 Asia Pacific Veterinary Pharmaceuticals Sales by Type (2013-2017)
7.3.2 Asia Pacific Veterinary Pharmaceuticals Revenue by Type (2013-2017)
7.4 Asia Pacific Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Veterinary Pharmaceuticals Market Status by Countries
8.1.1 Latin America Veterinary Pharmaceuticals Sales by Countries (2013-2017)
8.1.2 Latin America Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
8.1.3 Brazil Veterinary Pharmaceuticals Market Status (2013-2017)
8.1.4 Argentina Veterinary Pharmaceuticals Market Status (2013-2017)
8.1.5 Colombia Veterinary Pharmaceuticals Market Status (2013-2017)
8.2 Latin America Veterinary Pharmaceuticals Market Status by Manufacturers
8.3 Latin America Veterinary Pharmaceuticals Market Status by Type (2013-2017)
8.3.1 Latin America Veterinary Pharmaceuticals Sales by Type (2013-2017)
8.3.2 Latin America Veterinary Pharmaceuticals Revenue by Type (2013-2017)
8.4 Latin America Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Veterinary Pharmaceuticals Market Status by Countries
9.1.1 Middle East and Africa Veterinary Pharmaceuticals Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Veterinary Pharmaceuticals Revenue by Countries (2013-2017)
9.1.3 Middle East Veterinary Pharmaceuticals Market Status (2013-2017)
9.1.4 Africa Veterinary Pharmaceuticals Market Status (2013-2017)
9.2 Middle East and Africa Veterinary Pharmaceuticals Market Status by Manufacturers
9.3 Middle East and Africa Veterinary Pharmaceuticals Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Veterinary Pharmaceuticals Sales by Type (2013-2017)
9.3.2 Middle East and Africa Veterinary Pharmaceuticals Revenue by Type (2013-2017)
9.4 Middle East and Africa Veterinary Pharmaceuticals Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF VETERINARY PHARMACEUTICALS
10.1 Global Economy Situation and Trend Overview
10.2 Veterinary Pharmaceuticals Downstream Industry Situation and Trend Overview
CHAPTER 11 VETERINARY PHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Veterinary Pharmaceuticals by Major Manufacturers
11.2 Production Value of Veterinary Pharmaceuticals by Major Manufacturers
11.3 Basic Information of Veterinary Pharmaceuticals by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Veterinary Pharmaceuticals Major Manufacturer
11.3.2 Employees and Revenue Level of Veterinary Pharmaceuticals Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 VETERINARY PHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Zoetis(Pfizer)
12.1.1 Company profile
12.1.2 Representative Veterinary Pharmaceuticals Product
12.1.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Zoetis(Pfizer)
12.2 MERIAL
12.2.1 Company profile
12.2.2 Representative Veterinary Pharmaceuticals Product
12.2.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of MERIAL
12.3 Merial
12.3.1 Company profile
12.3.2 Representative Veterinary Pharmaceuticals Product
12.3.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Merial
12.4 Lilly
12.4.1 Company profile
12.4.2 Representative Veterinary Pharmaceuticals Product
12.4.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Lilly
12.5 Bayer
12.5.1 Company profile
12.5.2 Representative Veterinary Pharmaceuticals Product
12.5.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Bayer
12.6 Boehringer
12.6.1 Company profile
12.6.2 Representative Veterinary Pharmaceuticals Product
12.6.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Boehringer
12.7 Novartis
12.7.1 Company profile
12.7.2 Representative Veterinary Pharmaceuticals Product
12.7.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Novartis
12.8 Virbac
12.8.1 Company profile
12.8.2 Representative Veterinary Pharmaceuticals Product
12.8.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Virbac
12.9 Ceva
12.9.1 Company profile
12.9.2 Representative Veterinary Pharmaceuticals Product
12.9.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Ceva
12.10 Vetoquinol
12.10.1 Company profile
12.10.2 Representative Veterinary Pharmaceuticals Product
12.10.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Vetoquinol
12.11 CAHIC
12.11.1 Company profile
12.11.2 Representative Veterinary Pharmaceuticals Product
12.11.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of CAHIC
12.12 Ringpu
12.12.1 Company profile
12.12.2 Representative Veterinary Pharmaceuticals Product
12.12.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Ringpu
12.13 Dahuanong
12.13.1 Company profile
12.13.2 Representative Veterinary Pharmaceuticals Product
12.13.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Dahuanong
12.14 TECON
12.14.1 Company profile
12.14.2 Representative Veterinary Pharmaceuticals Product
12.14.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of TECON
12.15 BIOK
12.15.1 Company profile
12.15.2 Representative Veterinary Pharmaceuticals Product
12.15.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of BIOK
12.16 Lukang Pharma
12.17 JINYU Group
12.18 China Animal Healthcare
12.19 Jiangxi Yiling
12.20 JIZHONG Pharmaceutical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VETERINARY PHARMACEUTICALS
13.1 Industry Chain of Veterinary Pharmaceuticals
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF VETERINARY PHARMACEUTICALS
14.1 Cost Structure Analysis of Veterinary Pharmaceuticals
14.2 Raw Materials Cost Analysis of Veterinary Pharmaceuticals
14.3 Labor Cost Analysis of Veterinary Pharmaceuticals
14.4 Manufacturing Expenses Analysis of Veterinary Pharmaceuticals
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
